4.7 Review

Pathogenesis of Bronchopulmonary Dysplasia: Role of Oxidative Stress from 'Omics' Studies

Journal

ANTIOXIDANTS
Volume 11, Issue 12, Pages -

Publisher

MDPI
DOI: 10.3390/antiox11122380

Keywords

bronchopulmonary dysplasia (BPD); oxidative stress; antioxidants; epigenetics; transcriptomics; proteomics; metabolomics; newborn

Funding

  1. National Institute of Health/National Heart Lung Blood Institute (NIH/NHLBI)
  2. Stanley Manne Fellow Research Scholar Award
  3. [1K08HL14052]

Ask authors/readers for more resources

This article explores the interaction between oxidative stress (OS) and genetic regulation and reviews 'omics' data related to OS in bronchopulmonary dysplasia (BPD). It presents data from animal models and human studies, showing differential expression of OS-related genes in murine models mimicking BPD, premature infants at risk of BPD, and infants with established lung disease. The data from metabolomics and proteomics also suggest the potential involvement of OS-related pathways in BPD. However, the difficulty of obtaining timely and appropriate human samples remains a limitation in many studies.
Bronchopulmonary dysplasia (BPD) remains the most common respiratory complication of prematurity as younger and smaller infants are surviving beyond the immediate neonatal period. The recognition that oxidative stress (OS) plays a key role in BPD pathogenesis has been widely accepted since at least the 1980s. In this article, we examine the interplay between OS and genetic regulation and review 'omics' data related to OS in BPD. Data from animal models (largely models of hyperoxic lung injury) and from human studies are presented. Epigenetic and transcriptomic analyses have demonstrated several genes related to OS to be differentially expressed in murine models that mimic BPD as well as in premature infants at risk of BPD development and infants with established lung disease. Alterations in the genetic regulation of antioxidant enzymes is a common theme in these studies. Data from metabolomics and proteomics have also demonstrated the potential involvement of OS-related pathways in BPD. A limitation of many studies includes the difficulty of obtaining timely and appropriate samples from human patients. Additional 'omics' studies could further our understanding of the role of OS in BPD pathogenesis, which may prove beneficial for prevention and timely diagnosis, and aid in the development of targeted therapies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available